Montpellier, France

Pauline Scholler

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Cisbio Bioassays, Institut Jean Paoli & Irène Calmettes. Active years: 2019.


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pauline Scholler: Innovator in Antibody Research

Introduction

Pauline Scholler is a prominent inventor based in Montpellier, France. She has made significant contributions to the field of therapeutic and diagnostic applications through her innovative research. Her work focuses on the development of antibodies that target specific receptors, which can lead to advancements in medical treatments.

Latest Patents

Pauline Scholler holds a patent for "Anti-mGluR2 conformational single domain antibodies and uses thereof." This invention relates to anti-metabotropic glutamate receptor subtype 2 (mGluR2) conformational single domain antibodies and their applications, particularly in the therapeutic and diagnostic fields. She has 1 patent to her name, showcasing her expertise and dedication to innovation.

Career Highlights

Throughout her career, Scholler has worked with esteemed institutions such as the National Institute of Health and Medical Research and Université d'Aix-Marseille. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Daniel Baty and Jean-Philippe Pin. Their collaboration has further enriched her research and has led to advancements in the understanding of antibody applications.

Conclusion

Pauline Scholler is a remarkable inventor whose work in antibody research has the potential to impact therapeutic and diagnostic practices significantly. Her contributions to the field are invaluable, and her innovative spirit continues to inspire future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…